Novartis Cash and Equivalents vs. Market Capitalization

NVS -- USA Stock  

Fiscal Quarter End: December 31, 2019  

The Drivers Module shows relationships between Novartis's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Novartis AG over time as well as its relative position and ranking within its peers. Please see also Stocks Correlation

Novartis AG Market Capitalization vs. Cash and Equivalents Fundamental Analysis

Novartis AG is rated below average in cash and equivalents category among related companies. It is regarded fifth in market capitalization category among related companies creating about  23.36  of Market Capitalization per Cash and Equivalents.
Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Bank Deposits 
8.63 B
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually 3 months).
Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Market Cap 
Shares Outstanding 
Share Price 
201.57 B
In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.
Novartis AG is regarded fifth in market capitalization category among related companies. Market capitalization of Drug Manufacturers?General industry is now estimated at about 1.72 Trillion. Novartis retains roughly 201.57 Billion in market capitalization claiming about 12% of equities under Drug Manufacturers?General industry.
Capitalization  Total debt  Revenue  Workforce  Valuation

Novartis Fundamental Comparison